Advanced Accelerator Applications

LUTATHERA

Manufacturer:

Advanced Accelerator Applications

Lutathera HCPCS:

A9513

HCPCS Code Descriptor:

Lutetium lu 177, dotatate, therapeutic, 1 millicurie

Category:

A Code

Lutathera NDCs:

69488-0003-01

Primary Type:

Radiopharmaceutical

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Intravenous

Lutathera CPT Codes:

Potential CPT administration codes for Lutathera can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Lutathera:

LUTATHERA is a Radiopharmaceutical drug manufactured by Advanced Accelerator Applications and administered via the Intravenous route of administration. The A Code: A9513 is aligned to the drug LUTATHERA.

ACCESS PRICING AND MORE BY REGISTERING

A9513 Added Date:

January 1, 2019

A9513 Effective Date:

January 1, 2019

A9513 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Lutathera billing and coding information.
Lutathera patient assistance information can be found through Novartis Patient Support at the URL: https://www.novartis.us/our-products/patient-assistance/patient-assistance-foundation-enrollment
LUTATHERA prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for LUTATHERA. Please check back in a few weeks.